• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Walman Optical

Anonymous

Guest
I have a final interview next week with Walman Optical for the Xcel division. Have you heard of this company? Is it a good move from Medical Sales? Where do they stand in the industry? What is the realistic earning potential? How is management? Any feedback, I would great appreciate it. Thanks!
 




I have a final interview next week with Walman Optical for the Xcel division. Have you heard of this company? Is it a good move from Medical Sales? Where do they stand in the industry? What is the realistic earning potential? How is management? Any feedback, I would great appreciate it. Thanks!

Never heard of it.